Abnormal fetal growth, both growth restriction and overgrowth, is associated with perinatal
complications and an increased risk of metabolic and cardiovascular disease later in life …

The uptake and metabolism of long chain fatty acids (LCFA) are critical to many
physiological and cellular processes. Aberrant accumulation or depletion of LCFA underlie …

Long-chain fatty acyl-coenzyme As (CoAs) are critical regulatory molecules and metabolic
intermediates. The initial step in their synthesis is the activation of fatty acids by one of 13 …

The placenta is the primary interface between the fetus and mother and plays an important
role in maintaining fetal development and growth by facilitating the transfer of substrates and …

The developing fetus undergoes a dynamic period of rapid growth that is responsive to
changes in the in utero environment that may contribute to the development of fetal growth …

The prevalence of obesity during pregnancy continues to increase at alarming rates. This is
concerning as in addition to immediate impacts on maternal wellbeing, obesity during …

Introduction Primary human trophoblasts release a repertoire of extracellular vesicles (EVs).
Among them are nano-sized exosomes, which we found to suppress the replication of a …

Background: Obesity before pregnancy is associated with impaired metabolic status of the
mother and the offspring later in life. These adverse effects have been attributed to …

Background: Gestational diabetes mellitus (GDM) is associated with increased fetal
adiposity, which may increase the risk of obesity in adulthood. The placenta has insulin …

Fatty acid transport protein 2 (FATP2) is a multifunctional protein whose specific function is
determined by the type of located cell, its intracellular location, or organelle-specific …